CUMYL-THPINACA

CUMYL-THPINACA
Systematic (IUPAC) name
N-(1-Methyl-1-phenylethyl)-1-(tetrahydro-2H-pyran-4-yl)methyl-1H-indazole-3-carboxamide
Clinical data
Legal status
Identifiers
CAS Number 1400742-50-8
PubChem CID 86273679
Chemical data
Formula C23H27N3O2
Molar mass 377.5 g/mol

CUMYL-THPINACA (also known as SGT-42) is an indazole-3-carboxamide based synthetic cannabinoid.[1] CUMYL-THPINACA acts as a potent agonist for the cannabinoid receptors, with approximately 6x selectivity for CB1, having an EC50 of 0.1nM for human CB1 receptors and 0.59nM for human CB2 receptors.[2]

Legal status

Sweden's public health agency suggested to classify CUMYL-THPINACA as hazardous substance on November 10, 2014.[3]

As of October 2015 CUMYL-THPINACA is a controlled substance in China.[4]

See also

References

  1. ↑ "CUMYL-THPINACA". Cayman Chemical. Retrieved 11 July 2015.
  2. ↑ Bowden; et al. (11 April 2013). "Patent WO 2014167530 - Cannabinoid compounds". New Zealand Patent application 623626. Retrieved 11 July 2015.
  3. ↑ "Cannabinoider föreslås bli klassade som hälsofarlig vara". Retrieved 11 July 2015.
  4. ↑ "关于印发《非药用类麻醉药品和精神药品列管办法》的通知" (in Chinese). China Food and Drug Administration. 27 September 2015. Retrieved 1 October 2015.
This article is issued from Wikipedia - version of the Saturday, April 02, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.